Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,578 | -2,193 | -1,106 | N/A | N/A |
| Depreciation Amortization | 10 | 3 | 1 | N/A | N/A |
| Accounts receivable | 0 | -8 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 396 | 5 | 118 | N/A | N/A |
| Other Working Capital | 238 | 312 | 319 | N/A | N/A |
| Other Operating Activity | -305 | 13 | -77 | 0 | 0 |
| Operating Cash Flow | $-3,240 | $-1,869 | $-745 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -21 | -14 | -8 | N/A | N/A |
| Investing Cash Flow | $-21 | $-14 | $-8 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 738 | N/A | 984 | N/A | N/A |
| Other Financing Activity | 9,749 | 1,752 | 0 | 0 | 0 |
| Financing Cash Flow | $10,487 | $1,752 | $984 | $N/A | $N/A |
| Exchange Rate Effect | -35 | 34 | 7 | N/A | N/A |
| Beginning Cash Position | 314 | 411 | 173 | N/A | N/A |
| End Cash Position | 7,504 | 314 | 411 | N/A | N/A |
| Net Cash Flow | $7,191 | $-97 | $238 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,240 | -1,869 | -745 | N/A | N/A |
| Capital Expenditure | -21 | -14 | -8 | N/A | N/A |
| Free Cash Flow | -3,261 | -1,882 | -753 | 0 | 0 |